REGENXBIO, Inc. (RGNX)
10.08
-0.14
(-1.37%)
USD |
NASDAQ |
May 07, 11:00
REGENXBIO SG&A Expense (TTM) : 82.86M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 491.72M |
| Ocugen, Inc. | 21.13M |
| AbbVie, Inc. | 14.30B |
| Replimune Group, Inc. | 103.07M |
| Krystal Biotech, Inc. | 114.19M |